Albers Jeffrey W.

Spyre Therapeutics, Inc. · Director

Albers Jeffrey W. is listed in public filings as director. This Albers Jeffrey W. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Spyre Therapeutics, Inc. (SYRE), Kymera Therapeutics, Inc. (KYMR), and Blueprint Medicines Corporation (BPMC). Investors use Albers Jeffrey W.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Spyre Therapeutics, Inc.SYRE$582k8k sharesGrant / ExerciseMay 27, 2026$582.0K8k shares$72.51--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Kymera Therapeutics, Inc.KYMR$201k2.3k sharesSellDec 8, 2025$245.5K2.7k shares$89.32--
Kymera Therapeutics, Inc.KYMR$02.3k sharesSellDec 8, 2025$203.4K2.3k shares$90.30--
Kymera Therapeutics, Inc.KYMR$71k5k sharesGrant / ExerciseDec 8, 2025$70.9K5k shares$14.18--
Kymera Therapeutics, Inc.KYMR$05k sharesSellOct 13, 2025$295.9K5k shares$59.19--
Kymera Therapeutics, Inc.KYMR$05k sharesGrant / ExerciseOct 13, 2025$51.7K5k shares$10.34--
Blueprint Medicines CorporationBPMC$0170k sharesOtherJul 17, 2025$13.8M170k shares$81.44--
Blueprint Medicines CorporationBPMC$0110.5k sharesOtherJul 17, 2025$9.6M110.5k shares$86.60--
Blueprint Medicines CorporationBPMC$080k sharesOtherJul 17, 2025$8.0M80k shares$100.13--
Blueprint Medicines CorporationBPMC$090k sharesOtherJul 17, 2025$4.9M90k shares$54.13--
Blueprint Medicines CorporationBPMC$092.5k sharesOtherJul 17, 2025$3.3M92.5k shares$36.05--
Blueprint Medicines CorporationBPMC$015k sharesOtherJul 17, 2025$919.6K15k shares$61.31--
Blueprint Medicines CorporationBPMC$04.6k sharesOtherJul 17, 2025$485.1K4.6k shares$106.14--
Blueprint Medicines CorporationBPMC$05.3k sharesOtherJul 17, 2025$337.4K5.3k shares$63.66--
Blueprint Medicines CorporationBPMC--144.8k sharesOtherJul 17, 2025Disclosure amount unavailable144.8k shares----
Blueprint Medicines CorporationBPMC--144.8k sharesOtherJul 17, 2025Disclosure amount unavailable5.8k shares----
Kymera Therapeutics, Inc.KYMR$744k16k sharesGrant / ExerciseJun 25, 2025$743.5K16k shares$46.47--
Blueprint Medicines CorporationBPMC$19M150.5k sharesGrant / ExerciseJun 18, 2025$499.9K3.9k shares$128.12--
Kymera Therapeutics, Inc.KYMR$06.3k sharesSellJun 3, 2025$311.1K6.3k shares$49.00--
Kymera Therapeutics, Inc.KYMR$52k5k sharesGrant / ExerciseJun 3, 2025$65.6K6.3k shares$10.34--
Spyre Therapeutics, Inc.SYRE$389k25k sharesGrant / ExerciseMay 29, 2025$388.8K25k shares$15.55--
Blueprint Medicines CorporationBPMC$15M147.3k sharesSellMay 27, 2025$439.4K4.4k shares$101.02--
Blueprint Medicines CorporationBPMC$3.3M92.5k sharesGrant / ExerciseMay 27, 2025$180.3K5k shares$36.05--
Blueprint Medicines CorporationBPMC$15M146.6k sharesSellMay 27, 2025$66.3K650 shares$101.93--
Blueprint Medicines CorporationBPMC$14M154.2k sharesSellMar 12, 2025$499.4K5.7k shares$87.62--
Blueprint Medicines CorporationBPMC$3.5M97.5k sharesGrant / ExerciseMar 12, 2025$270.4K7.5k shares$36.05--
Blueprint Medicines CorporationBPMC$13M152.4k sharesSellMar 12, 2025$159.1K1.8k shares$88.37--
Blueprint Medicines CorporationBPMC$13M146.6k sharesSellMar 5, 2025$512.0K5.8k shares$88.80--
Blueprint Medicines CorporationBPMC$17M160k sharesSellJan 21, 2025$825.0K7.6k shares$109.11--
Blueprint Medicines CorporationBPMC$17M152.6k sharesSellJan 21, 2025$813.4K7.4k shares$109.92--
Blueprint Medicines CorporationBPMC$3.8M105k sharesGrant / ExerciseJan 21, 2025$360.5K10k shares$36.05--
Blueprint Medicines CorporationBPMC$17M152.4k sharesSellJan 21, 2025$22.1K200 shares$110.61--
Blueprint Medicines CorporationBPMC$16M157.6k sharesSellJan 13, 2025$511.4K5k shares$102.28--
Blueprint Medicines CorporationBPMC$4.1M115k sharesGrant / ExerciseJan 13, 2025$180.3K5k shares$36.05--
Blueprint Medicines CorporationBPMC$4.3M120k sharesGrant / ExerciseDec 19, 2024$540.8K15k shares$36.05--
Blueprint Medicines CorporationBPMC$15M163.5k sharesSellDec 19, 2024$461.1K5.2k shares$89.01--
Blueprint Medicines CorporationBPMC$15M159.7k sharesSellDec 19, 2024$346.4K3.8k shares$91.15--
Blueprint Medicines CorporationBPMC$15M168.6k sharesSellDec 19, 2024$346.1K3.9k shares$88.28--
Blueprint Medicines CorporationBPMC$14M157.6k sharesSellDec 19, 2024$193.1K2.1k shares$91.96--
Blueprint Medicines CorporationBPMC$16M157.6k sharesSellNov 7, 2024$510.0K5k shares$102.00--
Blueprint Medicines CorporationBPMC$4.9M135k sharesGrant / ExerciseNov 7, 2024$180.3K5k shares$36.05--
Spyre Therapeutics, Inc.SYRE$1.0M27.4k sharesSellNov 6, 2024$246.3K6.7k shares$36.76--
Spyre Therapeutics, Inc.SYRE$1.2M34.1k sharesSellOct 25, 2024$10.9K300 shares$36.43--
Blueprint Medicines CorporationBPMC$14M165.3k sharesSellSep 9, 2024$1.0M12k shares$85.86--
Blueprint Medicines CorporationBPMC$13M157.6k sharesSellSep 9, 2024$658.3K7.7k shares$85.12--
Blueprint Medicines CorporationBPMC$5.0M140k sharesGrant / ExerciseSep 9, 2024$360.5K10k shares$36.05--
Kymera Therapeutics, Inc.KYMR$05k sharesSellAug 26, 2024$245.5K5k shares$49.10--
Kymera Therapeutics, Inc.KYMR$52k5k sharesGrant / ExerciseAug 26, 2024$51.7K5k shares$10.34--